Evaluation of Effects of Chronic Dose Exposure to Cardioselective and Non-cardioselective Beta Blockers on Measures of Cardiopulmonary Function in Moderate to Severe COPD.

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Bisoprolol (Primary) ; Carvedilol (Primary) ; Beclometasone; Beclometasone/formoterol; Tiotropium bromide
Indications Chronic obstructive pulmonary disease
Focus Pharmacodynamics
Acronyms ANDA2

23 Apr 2019 Biomarkers information updated
04 Dec 2013 Accrual to date is 76% according to United Kingdom Clinical Research Network record.
03 Nov 2013 Accrual to date is 73% according to United Kingdom Clinical Research Network record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com